VETTORETTI, SIMONE
 Distribuzione geografica
Continente #
AS - Asia 3.207
NA - Nord America 972
SA - Sud America 744
EU - Europa 664
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.634
Nazione #
US - Stati Uniti d'America 924
SG - Singapore 902
VN - Vietnam 727
CN - Cina 670
HK - Hong Kong 599
BR - Brasile 574
RU - Federazione Russa 301
KR - Corea 153
DE - Germania 99
IT - Italia 90
AR - Argentina 79
FI - Finlandia 33
EC - Ecuador 30
IN - India 30
MX - Messico 26
GB - Regno Unito 24
ID - Indonesia 23
ZA - Sudafrica 23
BD - Bangladesh 22
NL - Olanda 22
FR - Francia 21
UA - Ucraina 17
SE - Svezia 15
CO - Colombia 14
IQ - Iraq 14
VE - Venezuela 14
CA - Canada 13
JP - Giappone 12
PY - Paraguay 12
PL - Polonia 10
TR - Turchia 10
AT - Austria 9
UZ - Uzbekistan 8
CL - Cile 7
PE - Perù 7
TN - Tunisia 6
UY - Uruguay 6
MY - Malesia 5
AL - Albania 4
EG - Egitto 4
PK - Pakistan 4
SA - Arabia Saudita 4
ES - Italia 3
IE - Irlanda 3
KE - Kenya 3
MA - Marocco 3
MM - Myanmar 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
PH - Filippine 2
TT - Trinidad e Tobago 2
AU - Australia 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.634
Città #
Hong Kong 599
Singapore 535
Hefei 337
Ashburn 230
Ho Chi Minh City 227
Hanoi 199
Seoul 153
Dallas 133
Buffalo 50
Los Angeles 49
The Dalles 48
Frankfurt am Main 46
São Paulo 46
Ann Arbor 37
Moscow 37
New York 27
Haiphong 20
Beijing 17
Biên Hòa 17
Thái Nguyên 17
Curitiba 16
Da Nang 16
Milan 16
Quận Bình Thạnh 16
Lappeenranta 15
Munich 15
Quận Một 15
Rio de Janeiro 15
Thái Bình 14
Chicago 13
Mexico City 13
Turku 13
Brasília 12
Quito 12
Vũng Tàu 12
Belo Horizonte 11
Ha Long 11
Hải Dương 10
Seattle 10
Wenzhou 10
Xiamen 10
Campinas 9
Can Tho 9
Salvador 9
Guayaquil 8
Houston 8
Huế 8
Rome 8
Santa Clara 8
Tashkent 8
Asunción 7
Chandler 7
Council Bluffs 7
Erbil 7
Guangzhou 7
Johannesburg 7
Ninh Bình 7
Quận Bốn 7
Tokyo 7
Warsaw 7
Bogotá 6
Cambridge 6
Denver 6
Fairfield 6
Guarulhos 6
Jakarta 6
Ningbo 6
Phoenix 6
Phủ Lý 6
Santo André 6
Wilmington 6
Wuhan 6
Amsterdam 5
Belém 5
Buenos Aires 5
Bắc Giang 5
Dhaka 5
Haarlem 5
Hortolândia 5
Hoàng Mai 5
London 5
Montevideo 5
Nuremberg 5
Osasco 5
Quận Năm 5
Salt Lake City 5
Sumaré 5
São Carlos 5
Teresina 5
Araçatuba 4
Bengaluru 4
Boardman 4
Brooklyn 4
Bắc Ninh 4
Campos dos Goytacazes 4
Caracas 4
Caxias do Sul 4
Düsseldorf 4
Elk Grove Village 4
Fortaleza 4
Totale 3.445
Nome #
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 257
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 161
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress 125
Peritoneal dialysis related peritonitis: insights from a long-term analysis of an Italian center 124
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 120
Importance of blood pressure control in chronic kidney disease 118
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 116
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 112
Serum uric acid and target organ damage in primary hypertension 109
Palliative and Supportive Dialysis: Current Practices and Recommendations for Best Clinical Practice 102
Poor Nutritional Status Is Associated with Death in a Population of Dialyzed Older Persons 102
Relationship between number of daily exchanges at CAPD start with clinical outcomes 101
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 101
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 100
Spontaneous low-protein intake in older CKD patients: one diet may not fit all 98
Frailty Is Associated with Malnutrition–Inflammation Syndrome in Older CKD Patients 97
A new CHA2DS2VASC score integrated with estimated glomerular filtration rate, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease 95
Simultaneous removal and replacement of the peritoneal catheter in CAPD patient with refractory peritonitis sustained by P. aeruginosa: A case-report 95
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 89
Corrigendum: Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study (Frontiers in Medicine, (2023), 10, (1221086), 10.3389/fmed.2023.1221086) 88
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease 88
What's New in the CKD-BMD Therapy? 88
Clinical Factors and Biomarkers Associated with Depressive Disorders in Older Patients Affected by Chronic Kidney Disease (CKD): Does the Advanced Glycation End Products (AGEs)/RAGE (Receptor for AGEs) System Play Any Role? 87
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease 84
Palliative and supportive dialysis: State of the art and recommendations for good clinical practice 83
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 72
Can Mediterranean Diet Have a Positive Impact on Kidney Health? A Pending Answer to a Long-Time Question 71
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 69
The Number of Medications Is Associated with Fractures in a Population of Dialyzed Older Patients with Frailty 69
Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease 67
Vulvar pyoderma gangrenosum with renal involvement 66
Calcium carbonate-enriched cheese to improve nutrition, compliance and phosphorus control in patients on kidney replacement therapy 64
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD 63
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction 62
Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study 61
Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease 60
Beyond cohort selection: An analytics-enabled i2b2 59
Advanced glycation end products (Age) and soluble forms of age receptor: Emerging role as mortality risk factors in CKD 59
Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy 59
Endothelial dysfunction in chronic kidney disease: Determinant of susceptibility to end-organ damage and therapeutic response 58
Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial 58
Use of the Frailty Index in Older Persons With Chronic Kidney Disease 55
Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease 55
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress 55
Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance 54
Frailty index and adverse outcomes in older patients in haemodialysis 54
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats 54
Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice 53
Microalbuminuria, cardiovascular, and renal risk in primary hypertension 53
Pulse pressure and subclinical cardiovascular damage in primary hypertension 53
Optimizing global risk evaluation in primary hypertension: The role of microalbuminuria and cardiovascular ultrasonography 52
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: A pilot study 52
Frailty in kidney transplantation: a review on its evaluation, variation and long-term impact 50
Mild renal dysfunction and renal vascular resistance in primary hypertension 50
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism 50
Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease 50
Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study 50
Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship 50
Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know? 50
Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease 49
MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation? 49
Patients with Hypertensive Nephropathy and Chronic Kidney Disease Might Not Benefit from Strict Blood Pressure Control 48
Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure? 48
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension 48
Creatinine clearance and signs of end-organ damage in primary hypertension 48
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 48
Prevention and treatment of diabetic nephropathy: The program for Irbesartan mortality and morbidity evaluation 48
Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats 47
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 47
Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status 47
In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition 46
Changes over time in ambulatory blood pressure and cardiac parameters predict cardiovascular outcome of patients with CKD and low cardiovascular morbidity 46
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension 45
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: An artificial neural network-based approach 45
Renal and cardiovascular protection in type 2 diabetes mellitus: Angiotensin II receptor blockers 44
The role of angiotensin II AT1 receptor antagonists in nephroprotection and cardioprotection in type 2 diabetes mellitus 43
Cardiovascular and Renal Risk Assessment as a Guide for Treatment in Primary Hypertension 43
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 43
Mild Renal Dysfunction and Cardiovascular Risk in Hypertensive Patients 42
Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study 42
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease 41
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation 41
Treatment of hyperuricemia in CKD 40
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension 40
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 37
Sarcopenia is associated with malnutrition but not with systemic inflammation in older persons with advanced CKD 33
Totale 5.895
Categoria #
all - tutte 14.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 38 1 6 4 5 5
2021/202232 5 8 6 2 1 5 0 0 2 0 1 2
2022/202357 5 14 9 8 9 7 0 0 2 1 0 2
2023/202414 1 2 2 1 0 5 0 0 2 0 0 1
2024/20252.461 1 6 2 2 3 1 15 4 558 541 331 997
2025/20263.272 574 790 606 892 361 49 0 0 0 0 0 0
Totale 5.895